| Literature DB >> 34029686 |
Emily Payne1, Kylee Harrington1, Philomena Richard1, Rebecca Brackin1, Ravin Davis1, Sarah Couture1, Jacob Liff1, Francesca Asmus1, Elizabeth Mutina1, Anyssa Fisher1, Denise Giuvelis2, Sebastien Sannajust2, Bahman Rostama3, Tamara King3, Lisa M Mattei4, Jung-Jin Lee4, Elliot S Friedman5, Kyle Bittinger4, Meghan May3, Glenn W Stevenson6.
Abstract
The present experiments determined the effects of the narrow-spectrum antibiotic vancomycin on inflammatory pain-stimulated and pain-depressed behaviors in rats. Persistent inflammatory pain was modeled using dilute formalin (0.5%). Two weeks of oral vancomycin administered in drinking water attenuated Phase II formalin pain-stimulated behavior, and prevented formalin pain-depressed wheel running. Fecal microbiota transplantation produced a non-significant trend toward reversal of the vancomycin effect on pain-stimulated behavior. Vancomycin depleted Firmicutes and Bacteroidetes populations in the gut while having a partial sparing effect on Lactobacillus species and Clostridiales. The vancomycin treatment effect was associated with an altered profile in amino acid concentrations in the gut with increases in arginine, glycine, alanine, proline, valine, leucine, and decreases in tyrosine and methionine. These results indicate that vancomycin may have therapeutic effects against persistent inflammatory pain conditions that are distal to the gut. PERSPECTIVE: The narrow-spectrum antibiotic vancomycin reduces pain-related behaviors in the formalin model of inflammatory pain. These data suggest that manipulation of the gut microbiome may be one method to attenuate inflammatory pain amplitude.Entities:
Keywords: Pain-depressed behaviors; amino acids; antibiotics; gut microbiome; rats; wheel running
Mesh:
Substances:
Year: 2021 PMID: 34029686 PMCID: PMC8578155 DOI: 10.1016/j.jpain.2021.05.003
Source DB: PubMed Journal: J Pain ISSN: 1526-5900 Impact factor: 5.820